Page 60 - FOR FLIP BOOK [single page]Cluster report 2018-2020 (1)

Quality Improvement as a result of Technology Advancement or Implementation of New Service Quality & Access Initiatives (continued)

Disease Specific Quality Indicators - Cancer (continued)
th
th
Waiting time (days) at 90 percentile for patients with breast cancer Waiting time (days) at 90 percentile for patients with nasopharynx cancer receiving first
receiving first treatment after diagnosis treatment after diagnosis
120 70
100 60
50
80
Days 60 Days 40
30
40
20
20 10
0 0
Previous periods Current period Previous periods Current period
Oct 2017 - Sep 2018 Apr 2018 - Mar 2019 Oct 2018 - Sep 2019 Apr 2018 - Mar 2019 Oct 2018 - Sep 2019 Apr 2019 - Mar 2020
NTEC 91 109 112 NTEC 62 59 62
Overall HA 69 73 78 Overall HA 58 59 61
Overall HA (Oct 2018 - Sep 2019) Overall HA (Apr 2019 - Mar 2020)
Disease Specific Quality Indicators - Diabetes Mellitus
% of diabetes mellitus patients with HbA1c < 7%
60%
50%
40%
30%
20%
10%
0%
Previous periods Current period
Apr 2018 - Mar 2019 Oct 2018 - Sep 2019 Apr 2019 - Mar 2020
NTEC 50.2% 49.4% 51.4%
Overall HA 51.2% 50.3% 52.3%
Overall HA (Apr 2019 - Mar 2020)
Disease Specific Quality Indicators - Hypertension
% of hypertension patients treated in GOPCs with blood pressure
<140/90 mmHg
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Previous periods Current period
Appendices - B. Hospital Statistical Report
Apr 2018 - Mar 2019 Oct 2018 - Sep 2019 Apr 2019 - Mar 2020
NTEC 74.4% 74.8% 74.1%
Overall HA 79.5% 78.6% 78.4%
Overall HA (Apr 2019 - Mar 2020)
Disease Specific Quality Indicators - End Stage Renal Disease
% of end stage renal disease patients receiving haemodialysis treatment
30%
25%
20%
15%
10%
5%
0%
Previous period Current period
as at 31 Dec 2018 as at 31 Dec 2019
NTEC 23.3% 23.7%
Overall HA 25.5% 26.0%
Overall HA (as at 31 Dec 2019)